Physician profile
Frederick A Godley
NPI 1508837816
$95,591.10
in general payments reported to CMS, 2019-2025
13 companies · $65K in 2025
The $65K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,100 · 2020: $14K · 2021: $6,602 · 2022: $5,499 · 2023: $1,557 · 2024: $1,841 · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $65K · Consulting Fee: $1,800 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,110 · Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $65,000.00 |
| Consulting Fee | $1,800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,110.00 |
| Food and Beverage | $764.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $65,240.45 | 2023-2025 | |
| Allergan, INC. | $19,015.07 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $5,395.74 | 2022 | |
| Amgen INC. | $2,068.69 | 2019-2023 | Aimovig |
| Aerin Medical INC. | $1,985.51 | 2023-2025 | |
| Pfizer INC. | $1,248.65 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $224.48 | 2021 | |
| Lundbeck LLC | $174.95 | 2021-2024 | |
| Eli Lilly and Company | $108.96 | 2019 | |
| Lilly USA, LLC | $60.00 | 2019 | |
| Inspire Medical Systems, INC. | $39.99 | 2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $16.45 | 2019 | |
| Impel Pharmaceuticals INC. | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Godley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.